The incidence of hypomagnesaemia comparing two magnesium supplement regimens in patients receiving cisplatinum-based chemotherapy: an observational study.

被引：0
|
作者：
Ootes, L. E. [1 ]
van der Drift, M. A. [1 ]
van den Hurk, D. [1 ]
Dekhuijzen, P. N. [2 ]
Timmer-Bonte, J. N. [2 ]
机构：
[1] Radboud Univ Nijmegen, Med Ctr, Groesbeek, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands
来源：
JOURNAL OF THORACIC ONCOLOGY | 2009年 / 4卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S965 / S965
页数：1
相关论文
共 48 条
  • [31] Assessment of weight gain in adult patients living with HIV receiving first-line dolutegravir-based or efavirenz-based ART regimens in routine care clinics in Tshwane district, South Africa: An observational study
    Sawry, Shobna
    Ayalew, Kassahun
    Maimela, Gloria
    Briggs-Hagen, Melissa
    van Wyk-Heath, Marelize
    Mthethwa, Simangele
    Shai, Sannie
    Mngomezulu, Nkululeko N.
    Tlhowe, Lawrence
    Achere-Darko, Josephine
    Bedford, Jason
    Martin, Catherine E.
    Fairlie, Lee
    Imrie, John
    HIV MEDICINE, 2024, 25 (07) : 826 - 839
  • [32] Intergenerational comparison of 5-HT3RA in the prevention of chemotherapy-induced nausea and vomiting in gastric cancer patients receiving cisplatin-based chemotherapy: an observational study using a Japanese administrative claims database
    Yuji Kunitomi
    Masayuki Nakashima
    Tomotsugu Seki
    Kazuki Ide
    Koji Kawakami
    Supportive Care in Cancer, 2021, 29 : 3951 - 3959
  • [33] Intergenerational comparison of 5-HT3RA in the prevention of chemotherapy-induced nausea and vomiting in gastric cancer patients receiving cisplatin-based chemotherapy: an observational study using a Japanese administrative claims database
    Kunitomi, Yuji
    Nakashima, Masayuki
    Seki, Tomotsugu
    Ide, Kazuki
    Kawakami, Koji
    SUPPORTIVE CARE IN CANCER, 2021, 29 (07) : 3951 - 3959
  • [34] Final results of a randomized phase II study of the EORTC Soft Tissue and Bone Sarcoma (STSBS) Group comparing two different ifosfamide (IF) regimens in chemotherapy untreated advanced soft tissue sarcoma (STS) patients (pts)
    van Oosterom, AT
    Krzemienlecki, K
    Nielsen, OS
    Judson, I
    Mouridsen, HT
    Svancarova, L
    Woll, P
    Spooner, D
    Hermans, C
    Van Glabbeke, M
    Verweij, J
    ANNALS OF ONCOLOGY, 1998, 9 : 115 - 115
  • [35] Phase II trial of depsipeptide (NSC-630176) in colorectal cancer patients who have received either one or two prior chemotherapy regimens for metastatic or locally advanced, unresectable disease: A Southwest Oncology Group study.
    Whitehead, R. P.
    Mccoy, S.
    Wollner, I. S.
    Wong, L.
    Harker, W. G.
    Hoff, P. M.
    Gold, P. J.
    Billingsley, K. G.
    Blanke, C. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 170S - 170S
  • [36] A Randomized Trial Comparing Plasma Drug Concentrations and Efficacies between 2 Nonnucleoside Reverse-Transcriptase Inhibitor-Based Regimens in HIV-Infected Patients Receiving Rifampicin: The N2R Study
    Manosuthi, Weerawat
    Sungkanuparph, Somnuek
    Tantanathip, Preecha
    Lueangniyomkul, Aroon
    Mankatitham, Wiroj
    Prasithsirskul, Wisit
    Burapatarawong, Sunantha
    Thongyen, Supeda
    Likanonsakul, Sirirat
    Thawornwa, Unchana
    Prommool, Vilaiwan
    Ruxrungtham, Kiat
    CLINICAL INFECTIOUS DISEASES, 2009, 48 (12) : 1752 - 1759
  • [37] Final results of a trial comparing two neoadjuvant chemotherapy (CT) regimens followed by surgery in patients with resectable non-small cell lung cancer (NSCLC): A phase II randomized study by the European Lung Cancer Working Party
    Berghmans, T.
    Lafitte, J.
    Giner, V.
    Berchier, M.
    Scherpereel, A.
    Paesmans, M.
    Meert, A.
    Bosschaerts, T.
    Leclercq, N.
    Sculier, J. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [38] Patients with non-Hodgkin's lymphoma receiving myelosuppressive chemotherapy with first and subsequent cycle pegfilgrastim support experience low rates of neutropenic complications: Preliminary results of FIRST, a prospective community-based study.
    Ozer, H
    Noga, SJ
    Morrison, VA
    Ding, BY
    Dansey, R
    BLOOD, 2005, 106 (11) : 256B - 256B
  • [39] The efficacy of bevacizumab in addition to platinum-based chemotherapy for first-line treatment of patients with advanced nonsquamous non-small-cell lung cancer (NSCLC): Final results of AVALANCHE, an observational cohort study.
    Tolnay, Edina
    Sarosi, Veronika
    Juhasz, Erthat
    Sztancsik, Zsuzsanna
    Losonczy, Gyorgy
    Ostoros, Gyula
    Mandoky, Laszlo
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [40] A randomized, double-blind, placebo-controlled phase Ill trial evaluating olanzapine 5 mg combined with standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based chemotherapy: J-FORCE Study.
    Hashimoto, Hironobu
    Abe, Masakazu
    Nakao, Masahiko
    Mizutani, Hideaki
    Sakata, Yasuhiko
    Fujita, Yukiyoshi
    Nishimura, Tomoyasu
    Hirano, Katsuya
    Okada, Hideaki
    Inui, Naoki
    Sakata, Yukio
    Iihara, Hirotoshi
    Zenda, Sadamoto
    Uchitomi, Yosuke
    Yamaguchi, Takuhiro
    Hoshina, Yukari
    Yanai, Takako
    Iwasa, Satoru
    Yamamoto, Noboru
    Ohe, Yuichiro
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345